PL2848254T3 - Pochodne pirazolu i ich zastosowanie w celach medycznych - Google Patents

Pochodne pirazolu i ich zastosowanie w celach medycznych

Info

Publication number
PL2848254T3
PL2848254T3 PL13787714T PL13787714T PL2848254T3 PL 2848254 T3 PL2848254 T3 PL 2848254T3 PL 13787714 T PL13787714 T PL 13787714T PL 13787714 T PL13787714 T PL 13787714T PL 2848254 T3 PL2848254 T3 PL 2848254T3
Authority
PL
Poland
Prior art keywords
medical purposes
pyrazole derivative
pyrazole
derivative
medical
Prior art date
Application number
PL13787714T
Other languages
English (en)
Polish (pl)
Inventor
Masayuki Isaji
Masaaki Takemura
Hidetoshi Isawa
Yukihiko Hotei
Itaru Miyashita
Original Assignee
Kissei Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co., Ltd. filed Critical Kissei Pharmaceutical Co., Ltd.
Publication of PL2848254T3 publication Critical patent/PL2848254T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13787714T 2012-05-07 2013-05-02 Pochodne pirazolu i ich zastosowanie w celach medycznych PL2848254T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012105847 2012-05-07

Publications (1)

Publication Number Publication Date
PL2848254T3 true PL2848254T3 (pl) 2017-03-31

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13787714T PL2848254T3 (pl) 2012-05-07 2013-05-02 Pochodne pirazolu i ich zastosowanie w celach medycznych

Country Status (15)

Country Link
US (2) US9273085B2 (https=)
EP (1) EP2848254B1 (https=)
JP (2) JP5663699B2 (https=)
KR (1) KR101868991B1 (https=)
CN (1) CN104284665B (https=)
AU (1) AU2013258566B2 (https=)
BR (1) BR112014027841B1 (https=)
CA (1) CA2872002C (https=)
DK (1) DK2848254T3 (https=)
ES (1) ES2601127T3 (https=)
MX (1) MX359988B (https=)
PL (1) PL2848254T3 (https=)
PT (1) PT2848254T (https=)
RU (1) RU2602739C2 (https=)
WO (1) WO2013168671A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3400944T3 (pl) 2010-11-04 2020-11-16 Albireo Ab Inhibitory ibat w leczeniu chorób wątroby
CA2872002C (en) * 2012-05-07 2019-01-15 Masayuki Isaji Pyrazole derivative and use thereof for medical purposes
EP2952206B1 (en) 2013-02-04 2018-10-24 Taisho Pharmaceutical Co., Ltd. Prophylactic or therapeutic drug for constipation
CN106573033A (zh) * 2014-06-25 2017-04-19 Ea制药株式会社 固体制剂及其稳定化方法
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
CA3094118A1 (en) 2018-03-28 2019-10-03 Avolynt Method for treating post-prandial hypoglycemia
ES2942443T3 (es) 2018-06-05 2023-06-01 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
BR112020024479A2 (pt) 2018-06-20 2021-03-02 Albireo Ab hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
HUE060905T2 (hu) 2019-02-06 2023-04-28 Albireo Ab Benzotiadiazepin vegyületek és azok alkalmazása epesav modulátorként
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
ES2973549T3 (es) 2019-12-04 2024-06-20 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP4188541B1 (en) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症(pfic)を処置するためのオデビキシバット
JP2024500309A (ja) 2020-12-04 2024-01-09 アルビレオ エービー ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
CN101511840A (zh) * 2006-04-26 2009-08-19 吉宁特有限公司 磷酸肌醇3-激酶抑制剂化合物及其使用方法
EP2228378B1 (en) * 2007-12-27 2015-09-09 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
EP2275430B1 (en) 2008-04-16 2012-05-16 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
TW201105336A (en) * 2009-07-01 2011-02-16 Kissei Pharmaceutical Combined medicine of pyrazole derivative and biguanide drug
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
CA2872002C (en) * 2012-05-07 2019-01-15 Masayuki Isaji Pyrazole derivative and use thereof for medical purposes

Also Published As

Publication number Publication date
KR101868991B1 (ko) 2018-06-19
EP2848254A4 (en) 2015-07-15
BR112014027841A2 (pt) 2017-06-27
MX359988B (es) 2018-10-18
AU2013258566B2 (en) 2017-03-16
KR20150013671A (ko) 2015-02-05
BR112014027841A8 (pt) 2021-09-28
CN104284665B (zh) 2016-11-16
JP2015083580A (ja) 2015-04-30
US9273085B2 (en) 2016-03-01
RU2602739C2 (ru) 2016-11-20
US20160129031A1 (en) 2016-05-12
JPWO2013168671A1 (ja) 2016-01-07
EP2848254B1 (en) 2016-08-03
JP6105546B2 (ja) 2017-03-29
RU2014149181A (ru) 2016-06-27
WO2013168671A1 (ja) 2013-11-14
HK1204773A1 (en) 2015-12-04
PT2848254T (pt) 2016-10-05
CA2872002C (en) 2019-01-15
CA2872002A1 (en) 2013-11-14
DK2848254T3 (en) 2016-10-31
ES2601127T3 (es) 2017-02-14
MX2014013696A (es) 2015-02-05
JP5663699B2 (ja) 2015-02-04
CN104284665A (zh) 2015-01-14
BR112014027841B1 (pt) 2022-08-09
AU2013258566A1 (en) 2014-11-27
US9694027B2 (en) 2017-07-04
US20150141631A1 (en) 2015-05-21
EP2848254A1 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
PL2848254T3 (pl) Pochodne pirazolu i ich zastosowanie w celach medycznych
GB2519257B (en) Magnetometer for medical use
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
PL2842945T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
EP2784074A4 (en) PYRAZOL CONNECTION AND ITS USE FOR MEDICAL PURPOSES
PT2882715T (pt) Derivados de pirazol e seu uso como antagonistas de lpar5
EP2832724A4 (en) NIPETIC ACID DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
PL2656843T3 (pl) Estry bendamustyny i związki pokrewne i ich medyczne zastosowanie
GB201215502D0 (en) Medical use
GB2502895B (en) Trouser Braces and Adaptor
GB201216381D0 (en) New compounds and medical uses
GB201208970D0 (en) New compounds and medical uses
ME03416B (me) Spoj pirazola i njegova farmaceutska upotreba